Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Magn Reson Chem ; 55(3): 210-213, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-27396835

RESUMO

The structure of a novel compound from Adansonia digitata has been elucidated, and its 1 H and 13 C NMR spectra have been assigned employing a variety of one-dimensional and two-dimensional NMR techniques without degradative chemistry. The Advanced Chemistry Development ACD/Structure Elucidator software was important for determining part of this structure that contained a fused bicyclic system with very few hydrogen atoms, which in turn, exhibited essentially no discriminating HMBC connectivities throughout that portion of the molecule. Copyright © 2016 John Wiley & Sons, Ltd.

2.
J Org Chem ; 81(22): 10631-10640, 2016 11 18.
Artigo em Inglês | MEDLINE | ID: mdl-27934476

RESUMO

An extract of Eudistoma sp. provided eudistidine C (1), a heterocyclic alkaloid with a novel molecular framework. Eudistidine C (1) is a racemic natural product composed of a tetracyclic core structure further elaborated with a p-methoxyphenyl group and a phenol-substituted aminoimidazole moiety. This compound presented significant structure elucidation challenges due to the large number of heteroatoms and fully substituted carbons. These issues were mitigated by application of a new NMR pulse sequence (LR-HSQMBC) optimized to detect four- and five-bond heteronuclear correlations and the use of computer-assisted structure elucidation software. Synthesis of eudistidine C (1) was accomplished in high yield by treating eudistidine A (2) with 4(2-amino-1H-imidazol-5-yl)phenol (4) in DMSO. Synthesis of eudistidine C (1) confirmed the proposed structure and provided material for further biological characterization. Treatment of 2 with various nitrogen heterocycles and electron-rich arenes provided a series of analogues (5-10) of eudistidine C. Chiral-phase HPLC resolution of epimeric eudistidine C provided (+)-(R)-eudistidine C (1a) and (-)-(S)-eudistidine C (1b). The absolute configuration of these enantiomers was assigned by ECD analysis. (-)-(S)-Eudistidine C (1b) modestly inhibited interaction between the protein binding domains of HIF-1α and p300. Compounds 1, 2, and 6-10 exhibited significant antimalarial activity against Plasmodium falciparum.


Assuntos
Alcaloides/síntese química , Compostos Heterocíclicos de 4 ou mais Anéis/síntese química , Biologia Marinha , Urocordados/química , Alcaloides/química , Animais , Espectroscopia de Ressonância Magnética Nuclear de Carbono-13 , Cromatografia Líquida de Alta Pressão , Compostos Heterocíclicos de 4 ou mais Anéis/química , Estrutura Molecular , Espectroscopia de Prótons por Ressonância Magnética , Espectrometria de Massas por Ionização por Electrospray
3.
Can J Public Health ; 100(5): 393-6, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19994746

RESUMO

OBJECTIVE: This paper aims to present the rates of drug-related hospital separations for amphetamines, alcohol, cocaine, cannabis and opioids for each province from fiscal years 1996 to 2005. METHOD: Data were drawn from Canada's Hospital Morbidity Database, a national electronic archive of all inpatient hospital admission records. All inpatient medical records with an alcohol- or drug-related diagnosis were abstracted for this study. RESULTS: Canadian rates increased during the 10-year period for all drugs; however, alcohol separations declined somewhat. The highest rates of drug and alcohol separations were most often found in BC, Alberta and the North. Nova Scotia and Newfoundland generally had the lowest rates of separations. CONCLUSION: The study provides a detailed provincial and national account of alcohol- and drug-related morbidity related to inpatient hospital admissions. The rates of alcohol-related admissions across all provinces were, by far, much greater than those associated with drug-related episodes. The data provide an important measure of the harms related to substance use in Canada.


Assuntos
Alcoolismo/epidemiologia , Hospitalização/estatística & dados numéricos , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Adolescente , Adulto , Canadá/epidemiologia , Bases de Dados Factuais , Feminino , Humanos , Pacientes Internados/estatística & dados numéricos , Classificação Internacional de Doenças/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Ontário/epidemiologia , Fatores de Risco , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA